Notably, Fusobacterium nucleatum not only drives the recruitment and differentiation of tumor-associated neutrophils (TANs) into pro-tumoral subtypes but also facilitates immune evasion while paradoxically enhancing the efficacy of anti-programmed death-ligand 1 (PD-L1) antibody therapy (Zhang and Pan, 2020). This evidence concerns the gene CD274 and neoplasm.